Canada
· Delayed Price · Currency is CAD Vext Science Statistics
Total Valuation
Vext Science has a market cap or net worth of CAD 60.19 million. The enterprise value is 108.19 million.
| Market Cap | 60.19M |
| Enterprise Value | 108.19M |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Vext Science has 245.67 million shares outstanding. The number of shares has increased by 42.82% in one year.
| Shares Outstanding | 245.67M |
| Shares Change (YoY) | +42.82% |
| Shares Change (QoQ) | +8.92% |
| Owned by Insiders (%) | 21.61% |
| Owned by Institutions (%) | 26.01% |
| Float | 174.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.11 |
| PB Ratio | 0.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.40 |
| EV / Sales | 2.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -53.15 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 44.21.
| Current Ratio | 1.58 |
| Quick Ratio | 0.28 |
| Debt / Equity | 44.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -25.86 |
| Interest Coverage | -4.48 |
Financial Efficiency
Return on equity (ROE) is -8.68% and return on invested capital (ROIC) is -8.59%.
| Return on Equity (ROE) | -8.68% |
| Return on Assets (ROA) | -7.69% |
| Return on Capital (ROIC) | -8.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.66% in the last 52 weeks. The beta is 1.73, so Vext Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.73 |
| 52-Week Price Change | -5.66% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 50.16 |
| Average Volume (20 Days) | 19,811 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vext Science had revenue of CAD 45.62 million and -9.49 million in losses. Loss per share was -0.05.
| Revenue | 45.62M |
| Gross Profit | 10.34M |
| Operating Income | -22.40M |
| Pretax Income | -8.42M |
| Net Income | -9.49M |
| EBITDA | -4.89M |
| EBIT | -22.40M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 4.64 million in cash and 52.64 million in debt, giving a net cash position of -48.00 million or -0.20 per share.
| Cash & Cash Equivalents | 4.64M |
| Total Debt | 52.64M |
| Net Cash | -48.00M |
| Net Cash Per Share | -0.20 |
| Equity (Book Value) | 119.07M |
| Book Value Per Share | 0.49 |
| Working Capital | 13.62M |
Cash Flow
In the last 12 months, operating cash flow was 674,515 and capital expenditures -2.71 million, giving a free cash flow of -2.04 million.
| Operating Cash Flow | 674,515 |
| Capital Expenditures | -2.71M |
| Free Cash Flow | -2.04M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 22.67%, with operating and profit margins of -49.11% and -20.80%.
| Gross Margin | 22.67% |
| Operating Margin | -49.11% |
| Pretax Margin | -18.47% |
| Profit Margin | -20.80% |
| EBITDA Margin | -10.71% |
| EBIT Margin | -49.11% |
| FCF Margin | -4.46% |
Dividends & Yields
Vext Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -42.82% |
| Shareholder Yield | -42.82% |
| Earnings Yield | -18.68% |
| FCF Yield | -3.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vext Science has an Altman Z-Score of 0.64. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.64 |
| Piotroski F-Score | n/a |